Advanced drug formation: Implants Flashcards

1
Q

What are the types of advanced drug technologies

A
  • Rate controlled

- Targeted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Advantages of controlled release vs conventional

A

-Less doses

>Less risk of overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors to consider when making sustained drugs

A
  1. Convenience and compliance
  2. Efficacy and safety
  3. Protection of franchises
  4. Adding value to generics
  5. Market expansion
  6. Creating new market
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Convenience and compliance

A
  • Slower release = less administration = better compliance

- Patient will prefer it in asymptomatic conditions such as hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Efficacy and safety

A

Short half-life so sustained release is preferred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Protection of franchise

A

Patent on drugs expires in 20 years, after that any manufacture can produce that drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adding value to Generics

A

When original patent is expired and can be sold at low prices.

Advanced technologies applied to generic to differentiate from other companies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Market expansion

A

Advanced tech can make it possible to administer drug via different routes.

Self-administration increases population that can benefit from the drug and so increases the market

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Creating new market

A

Gene therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the different types of drug release and their definitions

A
  • Delayed release: Release doesn’t start immediately
  • Repeat action: More that one dose released
  • Prolonged release: slow onset and slow release
  • Sustained release: Initial release plus gradual release
  • Rate-controlled release: drug release at controlled rate
  • Target drug delivery: drug released in specific location
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of implants and depots available

A

Non-degradable: Reservoir/matrix and solution and pore diffusion

Biodegradable: PLGA, Polyanhydrides and natural polymers

Pumps: osmotic and mechanical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advantages of rate controlling implants/depots

A

Convenience and compliance

Flexibility in dosage rate

No first pass or enzymatic metabolism

Commercially convenient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Disadvantages of implants/depot

A

Invasive

Termination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Disadvantages of implants/depot

A

Invasive

Termination

Failure

Limited loading

Biocompatibility issue

commercially expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Types of Non-degradable implants

A

Reservoir device: Drugs is surrounded by rate controlled polymer membrane

Matrix device: Drug is distributed throughout continuous phase composed if polymer or liquid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Fick’s first law and what is the equation

A

It is the rate that a substance diffuses across a unit area.

dm/dt = Dk/h x A x Conc. gradient

16
Q

What is Fick’s first law and what is the equation.

A

It is the rate that a substance diffuses across a unit area. Used in a reservoir system

dm/dt = Dk/h x A x Conc. gradient

  • D= diffusion coefficient
  • k= partition coefficient
  • h= thickness of membrane
  • A= surface area
17
Q

what is the limiting factor of a reservoir device

A

The memebrance

18
Q

What is the release rate of a matrix system

A

Amount of drug is proportion to per unit area = partition coefficient x half life
( M=kt1/2)

19
Q

What factors control the release of drugs in a matrix system

A
Initial conc.
Porosity
Tortuosity
Polymer employed 
Solubility of drug
20
Q

Limiting factor of the matrix device

A

The diffusion pathway

21
Q

Examples of an implants includes

A

Norplant: Subdermal implant contraceptive (levonorgestrel 30micrograms/day)
-silicone rubber membrane
Implanon: Subdermal implant of etonogestrel 40 micrograms/day
-Hybrid system: Matrix Core: EVA (28% vinyl acetate) more polar less affinity
Membrane: EVA (14% vinyl acetate) rate limiting diffusion step

22
Q

Limitations of non-degradable implants

A
  • Surgically removed
  • Application limited to neutral and hydrophobic molecules
  • Limited control over release
    • depends on characteristics of the polymer
23
Q

what is the degradation mechanism of biodegradable implants

A

Bio-erosion

Biodegradation

24
Q

What are the degradation patterns for the polymers

A
  • Bulk erosion: whole polymer subject to degradation

- Surface erosion: limited to the surface

25
Q

polymers use for biodegradable implants

A

Poly-lactide and poly-lactide-co-glycolide polymers (PLGA)

Lactid acid rich polymers are more stable against degradation

26
Q

what are the stages of polymer degradations

A
  • Polymer hydration
  • Rupture of ester linkages
  • Loss of mass, small parts become soluble and are absorbed
  • Phagocytosis of polymeric segments
27
Q

examples of biodegradable implants

A

-Zoladex: treat sex-hormones responsive tumours and endometriosis

28
Q

What matrix is used for Zoladex

A

Goserelon acetate dispersed in a bulk-eroding PLGA matrix

29
Q

What are the 2 combinations systems for dissolution-diffusion available

A

Swelling system: polymer absorbs water which dissolves the drugs
Biodegradable system: `dissolution of the polymer occurs in 2 different patterns
-Bulk erosion
-Surface erosion

30
Q

Examples of pumps

A

Duros (Alza)

Alzet minipumps

Synchromed pumps

MidiMed pumps